Ìý
Ìý
As of March 2022 we have a total of 29 early phase cancer clinical trials open to recruitment with 39 clinical trials currently in set-up.
TheÌýPie Chart below shows between January 2019 - April 2021 we had a total of 78 cancer clinical trials open to recruitment. The chart also shows how the portfolio looked by tumour group.
Our portfolio spreads across a diverse range of tumour groups. At this time the portfolio was dominated by clinical trials on Solid Tumours (trials investigating an IMP on multiple solid tumour types - often referred to as umbrella studies). The Haematology studies (divided into Myeloma and Lymphoma) also made up a large percentage of the portfolio.Ìý
Ìý
The below combined Line and Bar Graph shows our recruitment figures for the year 2021 (from 01 January 2021 - 30 December 2021).
Ìý